Bandekar A - Search Results

1

pH-dependent formation of lipid heterogeneities controls surface topography and binding reactivity in functionalized bilayers.

Kempegowda GB, Karve S, Bandekar A, Adhikari A, Khaimchayev T, Sofou S. Kempegowda GB, et al. Among authors: bandekar a. Langmuir. 2009 Jul 21;25(14):8144-51. doi: 10.1021/la9004032. Langmuir. 2009. PMID: 19594187

2

The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity.

Karve S, Bandekar A, Ali MR, Sofou S. Karve S, et al. Among authors: bandekar a. Biomaterials. 2010 May;31(15):4409-16. doi: 10.1016/j.biomaterials.2010.01.064. Epub 2010 Feb 26. Biomaterials. 2010. PMID: 20189243

3

Floret-shaped solid domains on giant fluid lipid vesicles induced by pH.

Bandekar A, Sofou S. Bandekar A, et al. Langmuir. 2012 Mar 6;28(9):4113-22. doi: 10.1021/la204765r. Epub 2012 Feb 22. Langmuir. 2012. PMID: 22276950

4

Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin.

Bandekar A, Karve S, Chang MY, Mu Q, Rotolo J, Sofou S. Bandekar A, et al. Biomaterials. 2012 Jun;33(17):4345-52. doi: 10.1016/j.biomaterials.2012.02.039. Epub 2012 Mar 17. Biomaterials. 2012. PMID: 22429980

5

Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.

Mamasheva E, O'Donnell C, Bandekar A, Sofou S. Mamasheva E, et al. Among authors: bandekar a. Mol Pharm. 2011 Dec 5;8(6):2224-32. doi: 10.1021/mp200079y. Epub 2011 Sep 21. Mol Pharm. 2011. PMID: 21899300

6

Masking and triggered unmasking of targeting ligands on liposomal chemotherapy selectively suppress tumor growth in vivo.

Bandekar A, Zhu C, Gomez A, Menzenski MZ, Sempkowski M, Sofou S. Bandekar A, et al. Mol Pharm. 2013 Jan 7;10(1):152-60. doi: 10.1021/mp3002717. Epub 2012 Dec 18. Mol Pharm. 2013. PMID: 23134440

7

Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer.

Bandekar A, Zhu C, Jindal R, Bruchertseifer F, Morgenstern A, Sofou S. Bandekar A, et al. J Nucl Med. 2014 Jan;55(1):107-14. doi: 10.2967/jnumed.113.125476. Epub 2013 Dec 12. J Nucl Med. 2014. PMID: 24337602 Free article.

8

Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues.

Zhu C, Bandekar A, Sempkowski M, Banerjee SR, Pomper MG, Bruchertseifer F, Morgenstern A, Sofou S. Zhu C, et al. Among authors: bandekar a. Mol Cancer Ther. 2016 Jan;15(1):106-113. doi: 10.1158/1535-7163.MCT-15-0207. Epub 2015 Nov 19. Mol Cancer Ther. 2016. PMID: 26586724 Free PMC article.

9

Topical inhibition of PUMA signaling mitigates radiation injury.

Kowzun MJ, Rifkin WJ, Borab ZM, Ellison T, Soares MA, Wilson SC, Lotfi P, Bandekar A, Sofou S, Saadeh PB, Ceradini DJ. Kowzun MJ, et al. Among authors: bandekar a. Wound Repair Regen. 2018 Nov;26(6):413-425. doi: 10.1111/wrr.12668. Epub 2018 Oct 25. Wound Repair Regen. 2018. PMID: 30155987

10

SDF-1 liposomes promote sustained cell proliferation in mouse diabetic wounds.

Olekson MA, Faulknor R, Bandekar A, Sempkowski M, Hsia HC, Berthiaume F. Olekson MA, et al. Among authors: bandekar a. Wound Repair Regen. 2015 Sep;23(5):711-23. doi: 10.1111/wrr.12334. Epub 2015 Sep 8. Wound Repair Regen. 2015. PMID: 26110250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters